Bank Of America Diverges On Aetna Inc, WellPoint Inc Ratings


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


The second and third-largest U.S. health insurers diverged in the ratings of an investment bank Monday.

Bank of America's Kevin Fischbeck boosted his rating on WellPoint Inc (NYSE: WLP) to Buy with a target of $140, while cutting his rating on Aetna Inc (NYSE: AET) to Neutral.

Investors have worried recently that new enrollees in Obamacare exchanges will boost medical spending and thus hurt profits of private insurers. This despite a string of upside earnings surprises in the recent quarter.

WellPoint, which plans to change its name to Anthem Inc. in November, hit a 52-week high last month after earnings beat Wall Street consensus on lower-than-expected medical costs as a percentage of premiums. Net profit, however, fell 8.6 percent.

Aetna similarly beat earnings expectations last month, but also posted higher medical costs that seemed to confirm investors' worries.

Aetna shares are up 5 percent in the past month, versus an 8 percent gain for WellPoint.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorUpgradesDowngradesPrice TargetAnalyst RatingsBank of AmericaKevin Fischbeck